Procter & GamblePGDON'T BUYDec 14, 2023Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
His theme for today is that he's really not that hot on the consumer. Of the whole economy, the consumer sector is the most exposed. Though a great company with a lot of good products, branded products tend to suffer when consumers are stretched. Growing about 3-5% revenue, 7-9% on earnings, trading at 23x. Pass. Better opportunities elsewhere.